How should I describe tinea pedis in a physical examination note?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Physical Examination Documentation for Tinea Pedis

Document tinea pedis by specifying the clinical type (interdigital, hyperkeratotic/moccasin, or vesiculobullous), describing the specific physical findings (scaling, erythema, fissures, maceration, or vesicles), noting the distribution pattern, and examining for associated findings like onychomycosis or concurrent skin involvement.

Essential Components to Document

Clinical Type Classification

Identify and document one of three primary presentations 1, 2:

  • Interdigital type: Most common presentation affecting the web spaces between toes
  • Hyperkeratotic (moccasin-type): Chronic plantar involvement with diffuse scaling
  • Vesiculobullous (inflammatory): Acute presentation with vesicle or bullae formation

Specific Physical Findings

Document these key features 3, 1:

  • Scaling: Describe extent and pattern (fine vs. thick desquamation)
  • Erythema: Note intensity and distribution
  • Fissures: Document location (particularly in interdigital spaces) as these create bacterial entry points and increase erysipelas risk 3
  • Maceration: Especially important in interdigital spaces
  • Vesicles or bullae: If present in inflammatory type
  • Pruritus level: Mild pruritus is typical 3
  • Pain or burning: Particularly when fissures are present 3

Distribution Pattern

Be specific about location 2:

  • Which interdigital spaces are affected
  • Unilateral vs. bilateral involvement
  • Plantar surface involvement (heel, arch, forefoot)
  • Lateral foot involvement
  • Dorsal foot (less common)

Associated Findings

Always examine and document 4, 1:

  • Toenail involvement: Onychomycosis is present in the majority of cases with tinea pedis; look for subungual hyperkeratosis, onycholysis, nail plate discoloration 4
  • Fingernail examination: Toenail infection nearly always precedes fingernail dermatophytosis 4
  • Other body sites: Check hands, groin, and other areas for spread 3
  • Surrounding skin: Document any secondary bacterial infection signs

Common Pitfalls to Avoid

Do not rely on clinical appearance alone 4. The accuracy of clinical diagnosis is low 1, and 50% of nail dystrophy cases are non-fungal 4. Always note in your documentation that mycological confirmation (KOH preparation or culture) is recommended before initiating treatment 4, 1.

Document risk factors when present 1, 5:

  • Immunosuppression
  • Diabetes mellitus
  • History of recurrent cellulitis (tinea pedis provides bacterial entry portal) 5

Sample Documentation Framework

"Bilateral feet examination reveals [interdigital/hyperkeratotic/vesiculobullous] tinea pedis with [specific findings: scaling/erythema/fissures/maceration] involving [specific locations]. Associated findings include [toenail changes/other body site involvement]. KOH preparation [performed/pending] for mycological confirmation."

This structured approach ensures comprehensive documentation while recognizing that tinea pedis can masquerade as other conditions including psoriasis, dermatitis, or eczema 6, 5, making mycological confirmation essential before treatment initiation.

References

Research

Tinea pedis: an updated review.

Drugs in context, 2023

Research

Foot mycoses - treatment with over-the-counter preparations based on clinical recommendations.

Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti, 2026

Guideline

guidelines for treatment of onychomycosis.

British Journal of Dermatology, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.